Clinical Trial Update: Vunakizumab Combined With Recaticimab in Subjects With Moderate to Severe Plaque Psoriasis and Dyslipidemia [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating the combination of vunakizumab and recaticimab for moderate to severe plaque psoriasis with dyslipidemia; the study is not yet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis

Drugs mentioned

• Recaticimab (recaticimab)
• Vunakizumab (Vunakizumab)

Snippet

Sponsor: Xiangya Hospital of Central South University | Conditions: Plaque Psoriasis | Phase 4 | Status: NOT_YET_RECRUITING